Applied DNA Sciences, Inc. (APDN)
NASDAQ: APDN · Real-Time Price · USD
0.157
-0.005 (-2.91%)
At close: Feb 21, 2025, 4:00 PM
0.159
+0.002 (1.53%)
After-hours: Feb 21, 2025, 7:54 PM EST
Applied DNA Sciences Employees
As of September 30, 2024, Applied DNA Sciences had 48 total employees, including 46 full-time and 2 part-time employees. The number of employees decreased by 7 or -12.73% compared to the previous year.
Employees
48
Change (1Y)
-7
Growth (1Y)
-12.73%
Revenue / Employee
$77,852
Profits / Employee
-$491,446
Market Cap
8.66M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
APDN News
- 8 days ago - Applied DNA Sciences, Inc. (APDN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Applied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress - Accesswire
- 10 days ago - Applied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025 - Accesswire
- 11 days ago - Applied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14 - Accesswire
- 6 weeks ago - Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates - Accesswire
- 6 weeks ago - Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter - Accesswire
- 2 months ago - Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA - Accesswire
- 2 months ago - Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines - Accesswire